Characteristic | β-coefficient | STAT | P Value |
---|
BMI, kg/m2 | −0.569 | −1.506 | 0.133 |
SBP, mmHg | −3.082 | −1.117 | 0.265 |
DBP, mmHg | −2.583 | −1.196 | 0.233 |
WC, cm | −0.440 | −0.373 | 0.709 |
HP, cm | −1.148 | −1.196 | 0.233 |
TP,g/L | 0.116 | 0.185 | 0.853 |
Albumin,g/L | 0.060 | 0.106 | 0.915 |
Globulin,g/L | −0.424 | −0.558 | 0.577 |
A/G | 0.039 | 0.897 | 0.370 |
TBIL, umol/L | 1.220 | 1.511 | 0.132 |
DBIL, umol/L | 0.703 | 1.542 | 0.124 |
TBA,umol/L | 0.154 | 0.156 | 0.876 |
ALT, U/L | 7.632 | 2.013 | 0.045 |
AST, U/L | 2.446 | 0.857 | 0.393 |
FBG, mmol/L | 0.025 | 0.130 | 0.897 |
LDL-C, mmol/L | −0.101 | −0.903 | 0.367 |
TG, mmol/L | −0.437 | −1.968 | 0.050 |
TC, mmol/L | −0.019 | −0.135 | 0.893 |
HDL-C, mmol/L | −0.003 | −0.080 | 0.936 |
- Abbreviations: BMI Body Mass Index, SBP systemic blood pressure, DBP diastolic blood pressure, WC Waist circumference, HP Hip circumference, TP Total Protein, A/G the ratio of albumin to globulin, TBIL total bilirubin, DBIL direct bilirubin, TBA total bile acid, ALT glutamic-pyruvic transaminase, AST glutamic oxalacetic transaminase, FBG fasting blood-glucose, LDL-C low density lipoprotein cholesterin, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, NAFLD nonalcoholic fatty liver disease
- aβ-coefficient: estimated quantitative effect of rs28365927 A Carriers on a phenotype of NAFLD, STAT: T statistic, P: level of statistical significance of the covariate(age and gender) adjusted linear regression analysis. P-value<0.05 considered as statistically significant (in bold)